NCT03515161

Brief Summary

The purpose of this study is to evaluate the performance of a novel closed-loop (automated) vasopressor administration system that delivers norepinephrine using feedback from standard operating room hemodynamic monitor (EV1000 Monitor-Flotrac or Clearsight system, Edwards Lifesciences, IRVINE, USA).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2018

Completed
9 days until next milestone

Study Start

First participant enrolled

April 26, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 3, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 27, 2018

Completed
Last Updated

September 14, 2018

Status Verified

September 1, 2018

Enrollment Period

4 months

First QC Date

April 17, 2018

Last Update Submit

September 13, 2018

Conditions

Keywords

closedloopvasopressor

Outcome Measures

Primary Outcomes (1)

  • Percentage of case Time in hypotension (MAP <65 mmHg) for surgical patients. For potential recrutment of critically ill patients in the ICU, this target can be different (higher, depending on the type of patient and comorbidities)

    The primary outcome will be the percentage of case time in predefined MAP target

    At postoperative day 1

Secondary Outcomes (2)

  • percentage of case time with MAP >75 mmHg with norepinephrine still running

    At postoperative day 1

  • Amount of vasopressors received

    At postoperative day 1

Study Arms (1)

Closed-loop

EXPERIMENTAL

Study patients will receive a baseline crystalloid infusion of 3 cc/kg/hr and all additional fluid management will be performed manually using the assisted fluid management sofware from the EV1000 monitor. A closed-loop system will automatically administer vasopressor based on the predefined target MAP chosen by the anesthesiologist in charge of the patient

Device: closed-loop

Interventions

Vasopressor admnistration in the closed loop group will be performed via a closed loop (automated) system that will use an infusion pump (Q-Core) and a controller (a computer run index and algorithm developed by Sironis) to make frequent, regular and accurate adjustments to the amount of vasopressor the patient receives using feedback from standard operating room monitors.

Closed-loop

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects over the age of 18
  • Subjects undergoing elective high risk surgery (either vascular-cardiac- or transplant)
  • Subjects requiring general anesthesia and mechanical ventilation
  • Subjects requiring cardiac output monitoring with an arterial line

You may not qualify if:

  • Subjects under 18 years of age
  • Subjects not undergoing surgery
  • Subjects not requiring general anesthesia or mechanical ventilation
  • Subjects not requiring cardiac output monitoring or an arterial line
  • Subject with Atrial Fibrillation
  • Subjects who are pregnant
  • Subjects without the capacity to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasme

Brussels, Brussels Capital, 1070, Belgium

Location

Related Publications (1)

  • Joosten A, Alexander B, Duranteau J, Taccone FS, Creteur J, Vincent JL, Cannesson M, Rinehart J. Feasibility of closed-loop titration of norepinephrine infusion in patients undergoing moderate- and high-risk surgery. Br J Anaesth. 2019 Oct;123(4):430-438. doi: 10.1016/j.bja.2019.04.064. Epub 2019 Jun 27.

MeSH Terms

Conditions

Teach-Back Communication

Condition Hierarchy (Ancestors)

CommunicationBehavior

Study Officials

  • Alexandre Joosten, M.D

    Erasme

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: SINGLE GROUP ASSIGNMENT
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 17, 2018

First Posted

May 3, 2018

Study Start

April 26, 2018

Primary Completion

August 27, 2018

Study Completion

August 27, 2018

Last Updated

September 14, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will share

We can provide individual patients data ( all hemodynamic data)

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
After the completion of the study and the publication of the results
Access Criteria
Contact PI

Locations